title: Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.
abstract: A challenge when designing membrane-active peptide antibiotics with therapeutic potential is how to ensure a useful antibacterial activity whilst avoiding unacceptable cytotoxicity for host cells. Understanding their mode of interaction with membranes and the reasons underlying their ability to distinguish between bacterial and eukaryotic cytoplasmic cells is crucial for any rational attempt to improve this selectivity. We have approached this problem by analysing natural helical antimicrobial peptides of anuran origin, using a structure-activity database to determine an antimicrobial selectivity index (SI) relating the minimal inhibitory concentration against Escherichia coli to the haemolytic activity (SI=HC(50)/MIC). A parameter that correlated strongly with SI, derived from the lengthwise asymmetry of the peptides' hydrophobicity (sequence moment), was then used in the "Designer" algorithm to propose novel, highly selective peptides. Amongst these are the 'adepantins', peptides rich in glycines and lysines that are highly selective for Gram-negative bacteria, have an exceptionally low haemolytic activity, and are less than 50% homologous to any other natural or synthetic antimicrobial peptide. In particular, they showed a very high SI for E. coli (up to 400) whilst maintaining an antimicrobial activity in the 0.5-4μM range. Experiments with monomeric, dimeric and fluorescently labelled versions of the adepantins, using different bacterial strains, host cells and model membrane systems provided insight into their mechanism of action.
authors.affiliation: Faculty of Science, University of Split, Split, Croatia.
authors.forename: Nada
authors.initials: N
authors.lastname: Ilić
authors.forename: Mario
authors.initials: M
authors.lastname: Novković
authors.forename: Filomena
authors.initials: F
authors.lastname: Guida
authors.forename: Daniela
authors.initials: D
authors.lastname: Xhindoli
authors.forename: Monica
authors.initials: M
authors.lastname: Benincasa
authors.forename: Alessandro
authors.initials: A
authors.lastname: Tossi
authors.forename: Davor
authors.initials: D
authors.lastname: Juretić
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry*; D001001:Anura; D001483:Base Sequence; D002942:Circular Dichroism; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004912:Erythrocytes / Q000187:drug effects / Q000382:microbiology; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D005998:Glycine / Q000737:chemistry; D006801:Humans; D008081:Liposomes / Q000737:chemistry; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry; D013329:Structure-Activity Relationship; D013499:Surface Properties; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D008081:Liposomes; D010455:Peptides; D005998:Glycine